Clinical Trial Update: Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets [Phase 1]

View source ↗

Summary

This is a Phase 1 bioequivalence study evaluating Sacubitril Alisartan Amlodipine tablets for primary hypertension; the study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Sacubitril Alisartan Amlodipine Tablets (sacubitril, alisartan, and amlodipine)

Snippet

Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. | Conditions: Primary Hypertension | Phase 1 | Status: NOT_YET_RECRUITING